Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SABRATEK CORP (SBTK) -- Ignore unavailable to you. Want to Upgrade?

To: mod who wrote (359)	7/20/1999 9:31:00 AM
From: Kevin Podsiadlik	Read Replies (2) \| Respond to of 487

Looks like Herb Greenberg read further through that S-3 than either of us. Do you know anything about this R&D agreement with a company called Systle, which only came into existence two days prior to the signing of the deal, and which resulted in SBTK booking a quick $1M out of nowhere, just in time to be counted for Q2?

To: mod who wrote (359)	7/20/1999 9:34:00 AM
From: RobbRacer	Respond to of 487

Mod, I did not know this would be a violation of the agreement. Crazy as it may be, some agreements allowing shorting as a hedge. Therefore if it was allowed all they would have to do is disclose they did to lock up profits and be liable for only the amount shorted above $20. The part you highlighted did not mention any restriction on shorting. If the stock is held in escrow this could never happen. If not in escrow, this could be done easily. I am not familiar with the agreement and was just thinking about all the angles. Rob